StockData
Stemtech Corp logo

Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Stemtech's profit margin for the twelve months ending Sep 30, 2026 was -191.3%. For fiscal 2025 it was -140.7%, against -74.6% the year before. The highest annual figure on record is -74.6% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-140.7%−66.1
FY2024Dec 31, 2024-74.6%+35.7
FY2023Dec 31, 2023-110.3%+77.1
FY2022Dec 31, 2022-187.4%−23.6
FY2021Dec 31, 2021-163.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ3 2026Sep 30, 2026-169.4%−74.4
Q2 FY2026CQ2 2026Jun 30, 2026-46.5%−4.5
Q1 FY2026CQ1 2026Mar 31, 2026-270.6%−102.9
Q4 FY2025CQ4 2025Dec 31, 2025-323.6%−293.4
Q3 FY2025CQ3 2025Sep 30, 2025-95.0%+18.5
Q2 FY2025CQ2 2025Jun 30, 2025-42.0%+17.1
Q1 FY2025CQ1 2025Mar 31, 2025-167.7%−65.1
Q4 FY2024CQ4 2024Dec 31, 2024-30.2%+106.8
Q3 FY2024CQ3 2024Sep 30, 2024-113.5%−33.2
Q2 FY2024CQ2 2024Jun 30, 2024-59.1%−33.7
Q1 FY2024CQ1 2024Mar 31, 2024-102.6%+94.8
Q4 FY2023CQ4 2023Dec 31, 2023-136.9%−88.9
Q3 FY2023CQ3 2023Sep 30, 2023-80.2%−1743.7
Q2 FY2023CQ2 2023Jun 30, 2023-25.4%+1929.1
Q1 FY2023CQ1 2023Mar 31, 2023-197.4%−154.6
Q4 FY2022CQ4 2022Dec 31, 2022-48.1%−32.6
Q3 FY2022CQ3 2022Sep 30, 20221663.5%–
Q2 FY2022CQ2 2022Jun 30, 2022-1954.5%–
Q1 FY2022CQ1 2022Mar 31, 2022-42.8%–
Q1 FY2021CQ1 2021Mar 31, 2021-15.5%–

More Stemtech figures

See a number that looks wrong?